Julia G. Butchko Immunovant, Inc. (IMVT) insider trading activity

IMVT Quotes by TradingView

Julia G. Butchko is Chief Development Officer of Immunovant, Inc.. Currently has a direct ownership of 440,959 shares of IMVT, which is worth approximately $12.1 Million. The most recent transaction as insider was on Aug 21, 2024, when has been sold 3,027 shares (Common Stock) at a price of $32.08 per share, resulting in proceeds of $97,106. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 441K
0% 3M change
7.22% 12M change
Total Value Held $12.1 Million

Julia G. Butchko Transaction History

Date Transaction Value Shares Traded Shares Held Form
Aug 21 2024
SELL
Open market or private sale
$97,106 $32.08 p/Share
3,027 Reduced 0.68%
440,959 Common Stock
Jul 17 2024
SELL
Open market or private sale
$86,268 $30.09 p/Share
2,867 Reduced 0.64%
443,986 Common Stock
Jul 09 2024
SELL
Open market or private sale
$42,847 $28.06 p/Share
1,527 Reduced 0.34%
446,853 Common Stock
May 22 2024
SELL
Open market or private sale
$96,273 $29.65 p/Share
3,247 Reduced 0.72%
448,380 Common Stock
Apr 17 2024
SELL
Open market or private sale
$297,077 $29.37 p/Share
10,115 Reduced 2.19%
451,627 Common Stock
Apr 09 2024
SELL
Open market or private sale
$32,832 $31.18 p/Share
1,053 Reduced 0.23%
461,742 Common Stock
Apr 02 2024
BUY
Grant, award, or other acquisition
-
54,978 Added 10.62%
462,795 Common Stock
Feb 22 2024
SELL
Open market or private sale
$77,577 $36.15 p/Share
2,146 Reduced 0.52%
407,817 Common Stock
Jan 05 2024
SELL
Open market or private sale
$50,051 $38.59 p/Share
1,297 Reduced 0.32%
409,963 Common Stock
Nov 22 2023
SELL
Open market or private sale
$108,202 $33.14 p/Share
3,265 Reduced 0.79%
411,260 Common Stock
Oct 05 2023
SELL
Open market or private sale
$62,407 $35.97 p/Share
1,735 Reduced 0.42%
414,525 Common Stock
Aug 24 2023
SELL
Open market or private sale
$253,936 $20.59 p/Share
12,333 Reduced 2.88%
416,260 Common Stock
Jul 12 2023
SELL
Open market or private sale
$29,003 $19.73 p/Share
1,470 Reduced 0.34%
428,593 Common Stock
Apr 18 2023
SELL
Open market or private sale
$23,576 $15.27 p/Share
1,544 Reduced 0.36%
430,063 Common Stock
Apr 12 2023
BUY
Grant, award, or other acquisition
-
100,188 Added 18.84%
431,607 Common Stock
Jan 11 2023
SELL
Open market or private sale
$966,630 $15.98 p/Share
60,490 Reduced 15.43%
331,419 Common Stock
Oct 13 2022
SELL
Open market or private sale
$8,519 $9.18 p/Share
928 Reduced 0.24%
391,909 Common Stock
Sep 28 2022
SELL
Open market or private sale
$2,498 $4.67 p/Share
535 Reduced 0.14%
392,837 Common Stock
Aug 30 2022
SELL
Open market or private sale
$3,195 $5.83 p/Share
548 Reduced 0.14%
393,372 Common Stock
Aug 17 2022
BUY
Grant, award, or other acquisition
-
112,816 Added 22.26%
393,920 Common Stock
Jul 27 2022
SELL
Open market or private sale
$2,178 $4.27 p/Share
510 Reduced 0.18%
281,104 Common Stock
Jun 29 2022
SELL
Open market or private sale
$1,849 $4.02 p/Share
460 Reduced 0.16%
281,614 Common Stock
May 24 2022
SELL
Open market or private sale
$1,865 $3.79 p/Share
492 Reduced 0.17%
282,074 Common Stock
Apr 27 2022
SELL
Open market or private sale
$2,554 $4.72 p/Share
541 Reduced 0.19%
282,566 Common Stock
Mar 24 2022
SELL
Open market or private sale
$37,648 $5.9 p/Share
6,381 Reduced 2.2%
283,107 Common Stock
JGB

Julia G. Butchko

Chief Development Officer
New York, NY

Track Institutional and Insider Activities on IMVT

Follow Immunovant, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells IMVT shares.

Notify only if

Insider Trading

Get notified when an Immunovant, Inc. insider buys or sells IMVT shares.

Notify only if

News

Receive news related to Immunovant, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on IMVT